Savior sibling

A savior baby or savior sibling is a child who is conceived in order to provide a stem cell transplant to a sibling that is affected with a fatal disease, such as cancer or Fanconi anemia, that can best be treated by hematopoietic stem cell transplantation.

Introduction

The savior sibling is conceived through in vitro fertilization. Fertilized zygotes are tested for genetic compatibility (human leukocyte antigen (HLA) typing), using preimplantation genetic diagnosis (PGD), and only zygotes that are compatible with the existing child are implanted. Zygotes are also tested to make sure they are free of the original genetic disease. The procedure is controversial.[1][2][3]

Indications

A savior sibling may be the solution for any disease treated by hematopoietic stem cell transplantation. It is effective against genetically detectable (mostly monogenic) diseases, e.g. Fanconi anemia,[4] Diamond–Blackfan anemia[5] and β-thalassemia, in the ailing sibling, since the savior sibling can be selected to not have inherited the disease. The procedure may also be used in children with leukemia, and in such cases HLA match is the only requirement, and not exclusion of any other obvious genetic disorder.

Procedure

8-cell human embryo, 3 days after fertilization

Multiple embryos are created and preimplantation genetic diagnosis is used to detect and select ones that are free of a genetic disorder and that are also a HLA match for an existing sibling who requires a transplant. Upon birth, umbilical cord blood is taken and used for hematopoietic stem cell transplantation.

Bioethical questions

The conception of a child in order to save another raises ethical issues, the sick eldest child being doomed, unless a compatible brother or sister can treat him or her.

This ethical debate is reflected in the terminology used, with opponents insisting on the term "baby‐medicine" to underline the "instrumentalization of the human body".[6] For these opponents, PGD is considered "utilitarianism taken to the extreme", "human procreation is totally diverted for the benefit of the project of creating a human being whose main "mission" is to be a medicine. Project carrying a radical alienation of one's freedom since its conception is only desired because of its therapeutic potential. He has no other choice than to take on the status of reservoir of cells for his sick elder, subject to a project predetermined by others, in this case society, the medical profession and his own parents."

The Jérome Lejeune Foundation, like other religious associations, which is anti-abortion, against research on embryos, but not against assisted procreation, speaks of a "double sorting baby", because this child is the survivor of a double sorting: the 1st in relation to the disease, the 2nd, in relation to compatibility,[7] thus wanting to criticize the selection of a large number of "healthy" embryos and therefore the "interruption of the life" of future babies, and therefore a eugenic drift. finally, these same opponents refuse the term "double hope baby", because it means the same practice as the expression "baby-medicine" - therefore the same criticisms apply[ref. necessary].

Specialists prefer to use "child of double hope": first hope of the birth of a healthy child, second hope of curing the eldest child, "the fact of being wanted for another does not exclude being wanted at the same time." "conceiving a child in the hope that it can cure someone is not in itself immoral, provided that it is not conceived exclusively for this purpose. We can reasonably hope that parents who love their child to the point of trying everything to save him will know how to love for himself the one by whom their first child was saved."

In 2002 the National Consultative Ethics Committee (CCNE) was reserved, recalling the "risk of instrumentalization of the unborn child" and that the "selection of an embryo and the initiation of a child conceived only as a potential donor, and not primarily for himself, is not thinkable in view of the values that he has always defended." However, he puts things into perspective by indicating that "allowing a desired child to represent, moreover, a hope of recovery for his eldest, is an acceptable objective, if he is second13." The Council of State questions: “The use of “double IPR” has remained exceptional (7 requests since the end of 2009). The hope offered to certain families in the face of suffering from an illness without a therapeutic solution seems not to have been fully satisfied. Therefore, it is not certain that the weight that double PGD places on the child resulting from it has found sufficient medical justification."[8].

French law rejects the concept of “medicine baby” but authorizes that of “double hope baby”.[9] In 2009, the CCNE recalled its 2002 opinion “allowing a desired child to represent hope of recovery for their eldest is an acceptable objective if he is second. As the current law provides, this extreme possibility should only be reserved for couples who have a child suffering from an illness leading to death. » A savior baby or savior sibling is a child who is conceived in order to provide a stem cell transplant to a sibling that is affected with a fatal disease, such as cancer or Fanconi anemia, that can best be treated by hematopoietic stem cell transplantation.

Laws

  • In the United Kingdom, the Human Fertilisation and Embryology Authority (HFEA) has ruled that it is lawful to use modern reproductive techniques to create a savior sibling.[5]
  • In Victoria, Australia, use of PGD for HLA typing is reviewed by the Infertility Treatment Authority on a case-by-case basis.[1]
  • In Spain The Cortes Generales approved the Assisted Reproduction Law in 2006, which authorizes preimplantation diagnosis for therapeutic purposes.
  • In France The bioethics law of July 7, 20115 now authorizes the practice of double PGD, going beyond the opinion of the Council of State and thus perpetuating a practice provisionally authorized by the bioethics law of August 2004, including the decree application published in the Official Journal of December 23, 2006. [10]

History

Yury Verlinsky and collaborators described the first case in 2001:[11] that of Adam Nash, born 29 August 2000.[12]

The novel My Sister's Keeper, later adapted into a film, is about a child who was born as a savior sibling to her sister Kate who is affected by acute promyelocytic leukemia.

In the British soap opera Emmerdale, Debbie Dingle gave birth to her son Jack, who would serve as a savior sibling to his older sister Sarah, who was suffering from Fanconi anemia.

On the popular American show CSI: Crime Scene Investigation, the episode "Harvest" deals with the reported abduction and later murder of a thirteen-year-old girl named Alycia who was later revealed to be a savior sibling for her brother Daniel.

In the American show Heroes, one of the protagonists, Mohinder Suresh, is revealed to have been conceived to cure his sister Shanti of a deadly disease known as the Shanti Virus, although he was ultimately born too late to save her life. His antibodies act as a cure for other patients with the disease throughout the show as well.

On Star Trek: Enterprise, the episode "Similitude" sees a clone created of Trip Tucker for the purpose of organ harvesting. "Sim" is born through the highly controversial use of an alien lifeform.

The novel Never Let Me Go, later adapted into a film, is centred around a dystopian future society where human clones are created and allowed to live to their teenage years before being used for organ harvesting. The film Parts: The Clonus Horror has a similar premise.

In the Grey's Anatomy episode "I Bet It Stung," the character Donna is a savior sibling to her older sister Reese.

In the 9-1-1 episode "Buck Begins", it is revealed that Evan "Buck" Buckley was conceived as a savior sibling for his older brother Daniel.

In the Korean Drama 'The Penthouse', the character Anna is adopted by a Korean-American family to be a savior sibling to their son, Logan Lee, who was suffering from bone marrow cancer at the time.

References

  1. Liu, Crystal K. (2007). "'Saviour Siblings'? The Distinction between PGD with HLA Tissue Typing and Preimplantation HLA Tissue Typing". Journal of Bioethical Inquiry. 4: 65–70. doi:10.1007/s11673-007-9034-9. S2CID 54515037.
  2. Sui, Suli; Sleeboom-Faulkner, Margaret (2010). "Choosing offspring: Prenatal genetic testing for thalassaemia and the production of a 'saviour sibling' in China". Culture, Health & Sexuality. 12 (2): 167–75. doi:10.1080/13691050902914110. PMID 19499399. S2CID 24115814.
  3. Bennett, B (2005). "Symbiotic relationships: Saviour siblings, family rights and biomedicine". Australian Journal of Family Law. 19 (3): 195–212. PMID 17058348.
  4. Moore, Pete (2007). The Debate About Genetic Engineering (Ethical Debates). New York, NY: Rosen Central. p. 29. ISBN 978-1-4042-3754-4.
  5. "Saviour sibling". worldwidewords.org. 11 August 2007.
  6. ""L'enfant du double espoir" n'est pas un "bébé médicament"". Le Monde.fr (in French). 15 February 2011. Retrieved 5 October 2023.
  7. "Fondation Jérôme Lejeune - Déficience intellectuelle d'origine génétique". Fondation Jérôme Lejeune (in French). Retrieved 5 October 2023.
  8. d'État, Le Conseil (5 October 2023). "Accueil - Conseil d'Etat". Conseil d'État (in French). Retrieved 5 October 2023.
  9. Fagniez, P. -L.; Loriau, J.; Tayar, C. (1 October 2005). "Du « bébé médicament » au « bébé du double espoir »". Gynécologie Obstétrique & Fertilité. 33 (10): 828–832. doi:10.1016/j.gyobfe.2005.07.034. ISSN 1297-9589. PMID 16139550.
  10. https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000789446
  11. "Preimplantation Diagnosis for Fanconi Anemia Combined With HLA Matching", Yury Verlinsky et al. The Journal of the American Medical Association.
  12. "What Are Savior Siblings & How Are They Created? - Cases & Ethics". inviTRA. 25 July 2018. Retrieved 18 April 2023.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.